A novel missense homozygous inactivating mutation in the fourth transmembrane helix of the luteinizing hormone receptor in leydig cell hypoplasia

American Journal of Medical Genetics

Volumn 130 A, Issue 2, 2004, Pages 146-153

  Leung, Michael Yiu Kwong ^a   Al Huslim, Osama ^b   Wu, Shao Hing ^a   Aziz, Andrew ^a   Inam, Ohail ^b   Awadh, Mohammed ^b   Rennert, Owen M ^a   Chan, Wai Yee ^a,c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Prince Sultan Military Medical City   (Saudi Arabia)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Inactivating mutation; Leydig cell hypoplasia; Luteinizing hormone receptor; Male pseudohermaphroditism

Indexed keywords

CYCLIC AMP; GREEN FLUORESCENT PROTEIN; LEUCINE; LUTEINIZING HORMONE RECEPTOR; NUCLEIC ACID BASE; PROLINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; EMBRYO; ESTROGEN THERAPY; EXON; FEMALE; GENE INACTIVATION; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPLASIA; KARYOTYPE 46,XY; LEYDIG CELL; LEYDIG CELL HYPOPLASIA; LIGAND BINDING; MALE PSEUDOHERMAPHRODITISM; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TESTIS;

ADOLESCENT; BASE SEQUENCE; CELL LINE; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GENITALIA, FEMALE; GREEN FLUORESCENT PROTEINS; HOMOZYGOTE; HUMANS; KARYOTYPING; LEYDIG CELLS; MALE; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; MUTATION, MISSENSE; RADIOLIGAND ASSAY; RECEPTORS, LH; RECOMBINANT FUSION PROTEINS; TESTIS;

EID: 4644313196     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.20681     Document Type: Article

References (24)

1. Ascoli M. 1983. An improved method for the solubilization of stable gonadotropin receptors. Endocrinology 113:2129-2134.
2. Berthezene F, Forest MG, Grimaud JA, Claustrat B, Mornex R. 1976. Leydig-cell agenesis: A cause of male pseudohermaphroditism. N Engl J Med 295:969-972.
3. Gromoll J, Eiholzer U, Nieschlag E, Simoni M. 2000. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: Differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 85:2281-2286.
4. Gromoll J, Schulz A, Borta H, Gudermann T, Teerds K, Greschniok A, Nieschlag E, Seif F. 2002. Homozygous mutation within the conserved Ala-Phe-Asn-Glu-Thr motif of exon 7 of the LH receptor causes male pseudohermaphroditism. Eur J Endocrinol 147:597-608.
5. Ji IH, Ji TH. 1991. Human choriogonadotropin binds to a lutropin receptor with essentially no N-terminal extension and stimulates cAMP synthesis. J Biol Chem 266:13076-13079.
6. Kremer H, Kraaij R, Toledo SPA, Post M, Fridman JB, Hayashida CY, Van Reen M, Milgrom E, Ropers HH, Mariman E, Themmen APN, Brunner HG. 1995. Male pseudohermaphroditism due to homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 9:160-164.
7. Latronico AC, Anasti J, Arnhold IJ, Rapaport R, Mendonca BB, Bloise W, Castro M, Tsigos C, Chrousos GP. 1996. Brief report: Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 334:507-512.
8. Latronico AC, Chai Y, Arnhold IJP, Liu X, Mendonca BB, Segaloff DL. 1998. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 12:442-450.
9. Laue L, Wu SM, Kudo M, Hsueh AJW, Griffin JE, Wilson JD, Grant DB, Berry AC, Cutler GB Jr, Chan WY. 1994. The gene defect that causes genetically XY males to develop as apparent females (Leydig cell hypoplasia). In: Selected biomedical research summaries. Third annual press book. American Society for Cell Biology. Bethesda, MD: American Society for Cell Biology, pp 1-3.
10. Laue L, Wu SM, Kudo M, Hsueh AJW, Cutler GB Jr, Griffin JE, Wilson JD, Brain C, Berry AC, Grant DB, Chan WY. 1995. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 8:1429-1433.
11. Laue L, Wu SM, Kudo M, Bourdony CJ, Cutler GB Jr, Hsueh AJW, Chan WY. 1996. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol 10:987-997.
12. Lloyd CE, Ascoli M. 1983. On the mechanisms involved in the regulation of the cell-surface receptors for human choriogonadotropin and mouse epidermal growth factor in cultured Leydig tumor cells. J Cell Biol 96:521-526.
13. Martens JWM, Verhoef-Post M, Abelin N, Ezabella M, Toledo SPA, Brunner HG, Themmen APN. 1998. A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: Correlation between receptor activity and phenotype. Mol Endocrinol 12:775-784.
14. Martens JWM, Lumbroso S, Verhoef-Post M, Georget V, Richter-Unruh A, Szarras-Czapnik M, Romer TE, Brunner HG, Themmen APN, Sultan CH. 2002. Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: Abnormal processing causes signaling deficiency. J Clin Endocrinol Metab 87:2506-2513.
15. Misrahi M, Meduri G, Pissard S, Bouvattier C, Beau I, Loosfelt H, Jolivet A, Rappaport R, Milgrom E, Bougneres P. 1997. Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab 62:2159-2165.
16. Nishi S, Nakabayashi K, Kobilka B, Hsueh AJW. 2002. The ectodomain of the luteinizing hormone receptor interacts with exoloop 2 to constrain the transmembrane region. J Biol Chem 277:3958-3964.
17. Richter-Unruh A, Martens JWM, Verhoef-Post M, Wessels HT, Kors WA, Sinnecker GHG, Boehmer A, Drop SLS, Toledo SPA, Brunner HG, Themmen APN. 2002. Leydig cell hypoplasia: Cases with new mutations, new polymorphisms, and cases without mutations in the luteinizing hormone receptor gene. Clin Endocrinol 56:103-112.
18. Rutgers JL, Scully RE. 1987. Pathology of the testis in intersex syndromes. Semin Diagn Pathol 4:275-291.
19. Stavrou SS, Zhu YS, Cai LQ, Katz MD, Herrera C, DeFillo-Ricart M, Imperato-McGinley J. 1998. A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 83:2088-2091.
20. Toledo SPA. 1992. Leydig cell hypoplasia leading to two different phenotype: Male pseudohermaphroditism and primary hypogonadism. Clin Endocrinol 36:521-522.
21. Wu SM, Chan WY. 1999. Male pseudohermaphroditism due to inactivating luteinzing hormone receptor mutation. Arch Med Res 30:495-500.
22. Wu SM, Hallermeier K, Laue L, Brain CC, Berry EC, Grant DB, Griffin JE, Wilson JD, Cutler GB Jr, Chan WY. 1998. Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol Endocrinol 12:1651-1660.
23. Xie YB, Wang H, Segaloff DL. 1990. Extracellular domain of lutropin/ choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. J Biol Chem 265:21411-21414.
24. Zenteno JC, Canto P, Kofman-Alfaro S, Mendez JP. 1999. Evidence for genetic heterogeneity in male pseudohermaphroditism due to Leydig cell hypoplasia. J Clin Endocr Metab 84:3803-3806.